HEALTH OF WOMAN. 2015.8(104):172–175 

Experience in using Vitex Agnus Castus in the complex of treatment of patients with polycystic ovary syndrome and infertility 

Artymuk N. V., Ustinova T. A., Vlasova V. V.

Department of obstetrics and gynecology № 2 (head. – prof.In. Artymuk) of Kemerovo state medical Academy

Kemerovo regional clinical hospital (chief physician Dr. med. Sciences V. E. Novikov)

Russian Bulletin of obstetrician-gynaecologist 2, 2011 

Polycystic ovary syndrome (PCOS) causes about 57% of all cases of endocrine infertility. For treatment of this disease, currently widely used surgical techniques. However, surgical intervention, enhances the level of prolactin that suppresses fertility. The study included 124 patients with PCOS and infertility after surgery (cauterization of the ovaries). The main group after surgery received a special herbal medicine extract Vitex Agnus castus Cyclodynon for 3 months. The control group – received no correction GPN. Result: the use of the drug Cyclodynon PCOS patients after surgery at baseline prolactin 500–1000 IU/L resulted in a statistically significant reduction in prolactin, increase in the level progesterone and on the frequency of ovulatory cycles. 

Key words: polycystic ovary syndrome, infertility, treatment, Vitex Agnus Castus, Сyclodynon. 

REFERENCES

1. Манухин ИБ, Геворкян МА, Макаришев АЯ. 2007. Повышение эффективности лечения бесплодия у пациенток с синдромом поликистозных яичников. Пробл. репрод. 5:74-76.

2. Назаренко ТА. 2005. Синдром поликистозных яичников. М:100-138.

3. Назаренко ТА. 2001. Эндокринное бесплодие у женщин. Гинекология 3:5:177-178.

4. Овсянникова ТВ. 2004. Эндокринное бесплодие у женщин при гиперпролактинемии. Гинекология 6:6:320-323.

5. Сметник ВП, Бутарева ЛБ. 2005. Опыт применения фитопрепарата "Циклодинон" ("Агнукастон") у пациеток с недостаточностью функции желтого тела и гиперпролактинемией. Пробл. репрод. 5:1-4.

6. Сутурина ЛВ, Аталян АВ, Колесникова ЛИ и др. 2008. К вопросу о механизмах нарушений репродуктивной функции женщин с гипепролактинемией: Съезд акушеров-гинекологов России, 4-й: Материалы. М:494-495.

7. Фитогормоны: Клиническая лекция. Под ред. ВЕ Радзинского, ИН Костина. М. 2003. 1:64.

8. Artymuk NV. 2010. Vitex agnus castus extract administered for luteal-phase defect treatment. J Reproduktionsmed Endokrinol. 7:362.

9. Cannichael AR, Can Vitex A. 2008. Agnus Castus be used for the treatment of mastalgia? What is the current evidence? Evid Based Complement Alternat Med 5:3:247-250. http://dx.doi.org/10.1093/ecam/nem074; PMid:18830450 PMCid:PMC2529385

10. Doll M. 2009. The premenstrual syndrome: effectiveness of Vitex agnus castus. Med Monatsschr Pharm 32:5:186-191. PMid:19469189

11. Freeman EW. 2010. Therapeutic management of premenstrual syndrome. Exp Opin Pharmacother 8:5. http://dx.doi.org/10.1517/14656566.2010.509344

12. Gjonnaess H. 1998. Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome. Fertil Steril 69:697-701. http://dx.doi.org/10.1016/S0015-0282(98)00006-5

13. Gorkow C, Wuttke W, Marz RW. 2002. Effectiveness of Vitex agnus-castus preparations. Wien Med Wochenschr 152:15-16:364-372. http://dx.doi.org/10.1046/j.1563-258X.2002.02055.x

14. Liu J, Burdette JE, Xu H et al. 2001. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49:2472-2479. http://dx.doi.org/10.1021/jf0014157; PMid:11368622

15. Ma L, Lin S, Chen R, Wang X. 2010. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynec Endocrinol 26:8:612-616. http://dx.doi.org/10.3109/09513591003632126; PMid:20334585

16. Merz PG, Gorkow C, Schrodter A et al. 1996. The effects of a special Agnus castus extract (BP1095E1) on prolactin secretion in healthy male subjects. Exp Clin Endocrinol Diabet 104:447-453. http://dx.doi.org/10.1055/s-0029-1211483; PMid:9021345

17. Mohammed E. 2005. Hyperprolactenaemia after laparoscopic ovarian drilling: an unknown phenomenon. Reprod Endocrin 3:3. http://dx.doi.org/10.1186/1477-7827-3-3; PMid:15644143 PMCid:PMC548144

18. Nasri S, Oryan S, Rohani AH, Amin GR. 2007. The effects of Vitex agnus castus extract and its interaction with dopaminergic system on LH and testosterone in male mice. Pak J Biol Sci, 15:10:14:2300-2307. http://dx.doi.org/10.3923/pjbs.2007.2300.2307

19. Prilepskaya VN. 2006. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas 55:55-63. http://dx.doi.org/10.1016/j.maturitas.2006.06.017

20. Roemheld-Hamm B. 2005. Chasteberry. Am Fam Physician 1:72:5:821-824.

21. Tesch BJ. 2003. Herbs commonly used by women: an evidence-based review. Am J Obstet Gynec 188:5:Suppl:44-55.